Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Drugs mediating myocardial protection
European Journal of Anaesthesiology, 11/12/09
De Hert SG et al. – The occurrence of myocardial ischaemia will result in either reversible or irreversible myocardial dysfunction. Even when revascularization is successful, some reperfusion injury may occur that transiently impairs myocardial function. The present contribution reviews a number of these strategies focusing on pharmacological treatments that have been developed to address myocardial reperfusion injury.
Related Articles
Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass
European Journal of Cardio-Thoracic Surgery, 10/01/09
Relevance Score: 67%
Infarct size and left ventricular function in the Proximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study
Heart, 11/11/09
Relevance Score: 66%
Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna
Journal of Pharmacy and Pharmacology, 11/06/09
Relevance Score: 66%
Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction
Hypertension, 11/09/09
Relevance Score: 65%
Randomized Comparison of Primary Percutaneous Coronary Intervention With Combined Proximal Embolic Protection and Thrombus Aspiration Versus Primary Percutaneous Coronary Intervention Alone in ST-Segment Elevation Myocardial Infarction
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 10/26/09
Relevance Score: 65%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases
Trends in Pharmacological Sciences, 03/15/10
Translational pharmacokinetic–pharmacodynamic modelling; application to cardiovascular safety data for PF-00821385, a novel HIV agent
British Journal of Clinical Pharmacology, 03/15/10
Differential effects of (beta)-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise
British Journal of Clinical Pharmacology, 03/15/10
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
Myocardial infarction and other major vascular events during chemotherapy for testicular cancer
Annals of Oncology, 03/15/10
The epidemiology and management of elderly patients with myocardial infarction or heart failure
Heart Failure Reviews, 03/15/10
Tachycardia-Induced Cardiomyopathy: Evaluation and Therapeutic Options
Congestive Heart Failure, 03/15/10
Article Search
Sponsor
Sponsor


See Latest Articles


